The cancelation of Ant Group’s IPO and Beijing’s request to reshape its activities have heralded major changes within the fintech company for the benefit of the Chinese government. According to the Wall Street Journal, the changes will soon be done. Senior Chinese officials have asked Alibaba’s financial branch to transform itself into a holding company.
The legal framework for financial holding companies provides for stricter supervision of shareholding, financing management, and more generally of the company while obliging investments in financial subsidiaries. Moreover, this holding company will be supervised by the Chinese Central Bank (PBOC). Thus, Beijing should be able to monitor and control Jack Ma’s company.
After months of turmoil, the fintech company has submitted a restructuring plan to the authorities. The details are not yet known but will be released shortly. A source close to the subject said that the matter should be settled in mid-February. Ant has formed a working group headed by its managing director, Simon Hu, and has appointed a compliance officer to lead the restructuring.
Read more about Ant Financial and find other important finance news with the Born2Invest mobile app.
Any changes will be made under the watchful eye of the Financial Stability and Development Committee, which will give final approval
According to PBOC Deputy Governor Pan Gongsheng, five major changes are being requested by the Chinese authorities: returning to the original payment activity, retaining personal data from lending activities, creating a financial holding company, changing governance, and reviewing asset management.
The issue of data is the sinews of the war, and the company has collected millions of data that are used to grant, or not grant, loans and financial services. Ant is currently working on the architecture of its databases in order to set up protocols compatible with those of the banks. Also, a less official objective for the State would be to take advantage of this holding company to distribute its digital yuan more widely when it is put into circulation.
Ant has “scorned” the laws and “indulged in regulatory arbitrage”, Beijing says stop
“Financial regulators were concerned about Ant’s regulatory arbitrage practices, which would have allowed the company to paint a positive picture of its financial situation and conceal the financial risks generated by its aggressive expansion into new business areas,” said Eswar Prasad, former head of the China Division at the International Monetary Fund.
Ant Group owns Alipay, which has more than one billion users in China. The payment application has processed more than $17 trillion in transactions and provided loans to some 500 million people. The latter activity has been strongly criticized by the authorities because fintech positions itself as an intermediary between the banks granting the loan and individuals. The risks to the company are thus largely minimized. For the government, this could threaten the banking system. In December 2020, following a meeting on Ant’s future, Pan Gongsheng criticized the group for “disregarding” laws and “engaging in regulatory arbitrage.
For the moment, opacity reigns. Neither a spokesman for Ant Group, nor the PBOC, nor the Chinese Banking and Insurance Regulatory Commission, nor the State Council have commented.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in SiecleDigital, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Solidarity Day 2022: Ganzourgou Producers Offer 2.6 Tons of Food to Vulnerable People
Regarding the selection criteria of vulnerable people, Ambroise Ouédraogo said that his association collaborates with the provincial directorate of Social...
Ford Chooses Almussafes over Germany for the Production of Electric Models
Thus, the Valencian factory will be the fifth Spanish factory to produce all-electric models. Stellantis manufactures electric models at its...
Surveillance Systems in High Demand as Public Safety Concerns Grow
Public safety concern is a national issue, and government officials are committed to enhancing safety. Surveillance systems of every type...
Delta Med (White Bridge Investments II) Buys AdriaMed’s Infusion Pumps
Delta Med is also active in the production and distribution in Italy and abroad of medical devices and disposable accessories...
Evenfi Raises +300,000 in 24 Hours in its Equity Crowdfunding Round
EvenFi was founded in Bergamo, Italy in 2018 as Criptalia by Diego Dal Cero and Mattia Rossi, and, launched in...
Biotech1 week ago
Satellos Bioscience’s Stem Cell Signaling Research Could Turn the Tables on Muscular Dystrophies
Crypto2 weeks ago
Solana Price Forecast: SOL Forms a Dead Cat Bounce
Crowdfunding2 weeks ago
Exporo Raises Funds, but the Company Value Decreases Instead of Increasing
Cannabis1 week ago
Luis Figo Launches His Brand of CBD Products